Reported Standalone quarterly numbers for Vista Pharmaceuticals are:Net Sales at Rs 0.38 crore in December 2020 down 94.32% from Rs. 6.73 crore in December 2019.
Quarterly Net Loss at Rs. 0.48 crore in December 2020 down 127.38% from Rs. 0.21 crore in December 2019.
EBITDA stands negative at Rs. 0.23 crore in December 2020 down 131.51% from Rs. 0.73 crore in December 2019.
Vista Pharma shares closed at 8.50 on February 19, 2021 (BSE) and has given -5.45% returns over the last 6 months and 1.19% over the last 12 months.
| Vista Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'20 | Sep'20 | Dec'19 | | Net Sales/Income from operations | 0.38 | 0.41 | 6.73 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 0.38 | 0.41 | 6.73 | | EXPENDITURE | | Consumption of Raw Materials | 0.25 | 0.37 | 5.58 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.33 | 0.38 | 0.38 | | Depreciation | 0.19 | 0.19 | 0.34 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.19 | 0.22 | 0.07 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.57 | -0.75 | 0.36 | | Other Income | 0.15 | 0.08 | 0.04 | | P/L Before Int., Excpt. Items & Tax | -0.42 | -0.67 | 0.39 | | Interest | 0.24 | 0.37 | 0.34 | | P/L Before Exceptional Items & Tax | -0.66 | -1.03 | 0.06 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.66 | -1.03 | 0.06 | | Tax | -0.17 | -1.39 | 0.27 | | P/L After Tax from Ordinary Activities | -0.48 | 0.36 | -0.21 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.48 | 0.36 | -0.21 | | Equity Share Capital | 7.36 | 7.36 | 6.07 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.13 | 0.11 | -0.07 | | Diluted EPS | -0.13 | 0.11 | -0.07 | | EPS After Extra Ordinary | | Basic EPS | -0.13 | 0.11 | -0.07 | | Diluted EPS | -0.13 | 0.11 | -0.07 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|